Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis

References

• Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–iv21.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Cheng H, Perez-Soler R. Leptomeningeal metastases in non-small-cell lung cancer. Lancet Oncol. 2018;19:e43–e55.
   PubMed Web of Science ®Google Scholar
• Rusch VW. Stage III non-small cell lung cancer. Semin Respir Crit Care Med. 2016;37:727–735.
   PubMed Web of Science ®Google Scholar
• Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27:167–170.
   PubMed Web of Science ®Google Scholar
• Das A, Gorospe M, Panda AC. The coding potential of circRNAs. Aging (Albany NY). 2018;10:2228–2229.
   PubMedGoogle Scholar
• Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev. 2018;48:121–127.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79.
   PubMed Web of Science ®Google Scholar
• Gu R, Shao K, Xu Q, et al. Circular RNA hsa_circ_0008003 facilitates tumorigenesis and development of non-small cell lung carcinoma via modulating miR-488/ZNF281 axis. J Cell Mol Med. 2020. DOI:10.1111/jcmm.15987.
   Web of Science ®Google Scholar
• Yan X, Wang T, Wang J. Circ_0016760 acts as a sponge of MicroRNA-4295 to enhance E2F transcription factor 3 expression and facilitates cell proliferation and glycolysis in nonsmall cell lung cancer. Cancer Biother Radiopharm. 2020. DOI:10.1089/cbr.2020.3621
   Web of Science ®Google Scholar
• Wang Y, Yin H, Chen X. Circ-LDLRAD3 enhances cell growth, migration, and invasion and inhibits apoptosis by regulating MiR-224-5p/NRP2 axis in gastric cancer. Dig Dis Sci. 2021. DOI:10.1007/s10620-020-06733-1
   Web of Science ®Google Scholar
• Yao J, Zhang C, Chen Y, et al. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sci. 2019;239:116871.
   PubMed Web of Science ®Google Scholar
• Xue M, Hong W, Jiang J, et al. Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137. RNA Biol. 2020;17:1811–1822.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314.
   PubMed Web of Science ®Google Scholar
• Huang WC, Chan SH, Jang TH, et al. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. 2014;74:751–764.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Y, Cao W, et al. miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2. Oncol Lett. 2018;16:6472–6478.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ren J, Hao S, et al. MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer. Am J Transl Res. 2018;10:525–534.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang H, Xie F, et al. Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis. Oncogene. 2020;39:1696–1709.
   PubMed Web of Science ®Google Scholar
• Gong F, Ren P, Zhang Y, et al. MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res. 2016;8:485–495.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang SS, Tao L, et al. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-kappaB signalling pathway in ovarian carcinoma. Sci Rep. 2019;9:8401.
   PubMed Web of Science ®Google Scholar
• Santoro R, Zanotto M, Carbone C, et al. MEKK3 sustains EMT and stemness in pancreatic cancer by regulating YAP and TAZ transcriptional activity. Anticancer Res. 2018;38:1937–1946.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ni X, Zhao L, et al. MiroRNA-188 acts as tumor suppressor in non-small-cell lung cancer by targeting MAP3K3. Mol Pharm. 2018;15:1682–1689.
   PubMedGoogle Scholar
• Tang H, Lv W, Sun W, et al. miR505 inhibits cell growth and EMT by targeting MAP3K3 through the AKTNFkappaB pathway in NSCLC cells. Int J Mol Med. 2019;43:1203–1216.
   PubMed Web of Science ®Google Scholar
• Xing S, Qu Y, Li C, et al. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT. J Cell Physiol. 2019;234:22657–22665.
   PubMed Web of Science ®Google Scholar
• De Fraipont F, Gazzeri S, Cho WC, et al. Circular RNAs and RNA splice variants as biomarkers for prognosis and therapeutic response in the liquid biopsies of lung cancer patients. Front Genet. 2019;10:390.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25:1–7.
   PubMed Web of Science ®Google Scholar
• Guo J, Luo C, Yang Y, et al. MiR-491-5p, as a tumor suppressor, prevents migration and invasion of breast cancer by Targeting ZNF-703 to regulate AKT/mTOR pathway. Cancer Manag Res. 2021;13:403–413.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Z, Li Y, et al. Long non-coding RNA H19 promotes proliferation, migration and invasion and inhibits apoptosis of breast cancer cells by targeting miR-491-5p/ZNF703 axis. Cancer Manag Res. 2020;12:9247–9258.
   PubMed Web of Science ®Google Scholar
• Qi G, Li L. LncRNA TTN-AS1 promotes progression of non-small cell lung cancer via regulating miR-491-5p/ZNF503 axis. Onco Targets Ther. 2020;13:6361–6371.
   PubMedGoogle Scholar
• Zhang L, Zhang Y, Wang S, et al. MiR-212-3p suppresses high-grade serous ovarian cancer progression by directly targeting MAP3K3. Am J Transl Res. 2020;12:875–888.
   PubMed Web of Science ®Google Scholar
• Gui D, Cao H. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458. In Vitro Cell Dev Biol Anim. 2020;56:24–33.
   PubMed Web of Science ®Google Scholar
• Yin W, Shi L, Mao Y. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression. FEBS Open Bio. 2019;9:43–52.
   PubMed Web of Science ®Google Scholar